Skip to main content
Ambu logo

Ambu — Investor Relations & Filings

Ticker · AMBU ISIN · DK0060946788 LEI · 5299008W2A69WX355710 CO Manufacturing
Filings indexed 1,332 across all filing types
Latest filing 2016-04-12 Transaction in Own Shar…
Country DK Denmark
Listing CO AMBU

Ambu is a global medical technology company that develops, manufactures, and markets single-use medical devices. A pioneer and market leader in single-use endoscopy, the company provides a broad portfolio of solutions for healthcare professionals across various clinical areas, including endoscopy, anesthesia, and patient monitoring. Its key products include the aScope™ line of single-use flexible endoscopes for pulmonology, gastroenterology, and urology, as well as video laryngoscopes. Ambu's solutions are designed to improve patient safety by eliminating the risk of cross-contamination associated with reusable devices, while also enhancing workflow efficiency in clinical environments by ensuring sterile, high-quality equipment is always available.

Recent filings

Filing Released Lang Actions
Transaction in Own Shares 2016
Transaction in Own Shares Classification · 100% confidence The document text explicitly states that 'Ambu initiated two parallel share buyback programmes for the purpose of hedging share-based incentive programmes.' The term 'share buyback' directly corresponds to the definition of 'Transaction in Own Shares' (POS), which covers the company buying back or selling its own shares.
2016-04-12 English
Transaction in Own Shares 2016
Transaction in Own Shares Classification · 99% confidence The document explicitly details transactions conducted under a 'Buyback programme' between specific dates (April 1 to April 11, 2016) related to the company purchasing its own shares, categorized into 'Safe Harbour rules' and 'outside the Safe Harbour rules'. This activity directly corresponds to the definition of a company reporting on the repurchase or sale of its own shares. Therefore, the appropriate filing type is Transaction in Own Shares (POS). The document length is moderate, and it is a direct report of the activity, not an announcement of a report.
2016-04-12 English
Aktietilbagekøbsprogram
Transaction in Own Shares Classification · 100% confidence The document is a corporate announcement from Ambu detailing specific transactions related to their share buyback program (Aktietilbagekøbsprogram). It provides a table of daily share purchases, transaction values, and the total number of treasury shares held. This falls directly under the definition of 'Transaction in Own Shares' (POS).
2016-04-12 English
Aktietilbagekøbsprogram
Transaction in Own Shares Classification · 95% confidence The document announces that Ambu initiated two parallel share buyback programs on 11 November 2015, which is a transaction in the company’s own shares. This clearly falls under the "Transaction in Own Shares" category (POS).
2016-04-12 Danish
Capital/Financing Update 2016
Capital/Financing Update Classification · 95% confidence The document is a short announcement (2774 characters) dated April 7, 2016, detailing the acquisition of intellectual property (patents) related to breathing circuits for $9 million USD. It explicitly mentions that the purchase price will be reported in the cash flow statement of the 'delårsrapporten for 2. kvartal 2015/16' (interim report for Q2 2015/16) to be published on May 3, 2016. The core subject is a significant financing/transaction activity (acquisition of IP/technology) that impacts the capital structure and future financials, but it is not the full interim report itself. This type of announcement regarding a specific transaction or financing activity aligns best with the 'Capital/Financing Update' category (CAP). It is not a general regulatory filing (RNS) because it fits a more specific category, nor is it a management report (MDA) which usually discusses broader business trends alongside results.
2016-04-07 English
Capital/Financing Update 2016
Capital/Financing Update Classification · 99% confidence The document text is extremely short (109 characters) and contains high-level strategic and financial outlook commentary for a future period (2015/16). It does not contain the structure or detail of a full report (10-K, IR), an earnings release (ER), or a specific announcement like a dividend (DIV) or management change (MANG). Given the brevity and general nature of the update, it most closely resembles a brief statement or update that might accompany a larger filing or be a standalone, non-standard announcement. Since it lacks specific keywords for the defined categories (like AGM, Audit, Director Dealing, etc.), and it is not clearly an announcement *about* a report (RPA), the most appropriate fallback category for a brief, general corporate update that doesn't fit elsewhere is Regulatory Filings (RNS).
2016-04-07 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.